Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Mineralization outside current pit-constrained indicated 2.08M ounce resourceApprox. 76,600m of planned 80,000m drill program completedResource update on schedule for Q3 2022 VANCOUVER, British...
-
CALGARY, Alberta, June 07, 2022 (GLOBE NEWSWIRE) -- PayShepherd, a global provider helping heavy industrial facilities manage contractor billing, today announces it has secured US$3M in seed funding...
-
PHILADELPHIA, PA, June 07, 2022 (GLOBE NEWSWIRE) -- HHM and Urgo Hotels & Resorts (“Urgo”) have entered into a definitive agreement that, upon closing, will result in Urgo becoming a wholly...
-
VANCOUVER, British Columbia, June 07, 2022 (GLOBE NEWSWIRE) -- Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) is pleased to announce the successful completion of the...
-
TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- Patriot One Technologies (TSX: PAT) (OTCQX: PTOTF) (FRA: 0PL) (“Patriot One” or the “Company”) today announced it has signed a 24-month, $1 million CAD...
-
TORONTO, June 04, 2022 (GLOBE NEWSWIRE) -- To mark Tom Longboat Day, Historica Canada has released a new Heritage Minute that tells the story of the Onondaga distance runner from Six Nations of the...
-
Surrey, BC/Territories of the Coast Salish (Kwantlen, Katzie, Semiahmoo, Tsawwassen first nations), June 02, 2022 (GLOBE NEWSWIRE) -- Westland Insurance Group announced today that it has acquired...
-
Vancouver, June 01, 2022 (GLOBE NEWSWIRE) -- The Canadian arm of the REACH real estate technology scale-up program is now accepting applications for its 2023 cohort. The award-winning REACH program...
-
TORONTO, June 01, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- SiGMA, the world’s leading hub in iGaming, including regulation, responsible gambling, and marketing, today announces that it will host...
-
PARAMUS, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company focused on genetically screening, discovering and developing safe, effective and...